In a recent post on the IVI-sponsored Health Affairs featured blog series, John Fox and Marc Waltrous provide a detailed analysis of the Genentech-Priority Health Pilot program, outlining the background, key considerations, pilot design, and take-aways to illustrate the challenges of a successful outcomes-based contracting agreement.
Read the full article here.
About the Health Affairs/IVI Featured Blog Series: Drugs and Medical Innovation — In partnership with Health Affairs, IVI is proud to sponsor the “Drugs and Medical Innovation” blog series. On an ongoing basis, articles in this series will explore topics such as value-based reimbursement, drug policy and pricing, balancing short-term access against long-term rates of innovation, and other relevant issues. Our goal is to create an open forum for sharing ideas and debating issues in these areas, extending the discussion to a broader audience.